Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial

被引：0
|
作者：
Ison, Michael G. [1 ]
Castro, Rita de Cassia [2 ]
Hurt, Aeron C. [3 ]
Ko, Jinnie [2 ]
Yau, Linda [2 ]
Kuhlbusch, Klaus [3 ]
Portsmouth, Simon [4 ]
Hayden, Frederick G. [5 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] F Hoffmann Roche Ltd, Basel, Switzerland
[4] Shionogi Inc, Florham Pk, NJ USA
[5] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 116卷
关键词：
influenza; diabetes; antiviral; baloxavir; oseltamivir;
D O I：
10.1016/j.metabol.2020.154624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0157
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [41] Semaglutide in patients with non-alcoholic steatohepatitis: subgroup analysis of a randomised, placebo-controlled phase 2 trial
    Francque, Sven
    Kjaer, Mette
    Ladelund, Steen
    Okanoue, Takeshi
    Mateva, Lyudmila
    Shrestha, Ichhya
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S609 - S610
  • [42] Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
    Kelley, Robin Kate
    Ryoo, Baek-Yeol
    Merle, Philippe
    Park, Joong-Won
    Bolondi, Luigi
    Chan, Stephen L.
    Lim, Ho Yeong
    Baron, Ari D.
    Parnis, Francis
    Knox, Jennifer
    Cattan, Stephane
    Yau, Thomas
    Lougheed, Julie C.
    Milwee, Steven
    El-Khoueiry, Anthony B.
    Cheng, Ann-Lii
    Meyer, Tim
    Abou-Alfa, Ghassan K.
    ESMO OPEN, 2020, 5 (04) : 1 - 9
  • [43] Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes A FIDELITY Subgroup Analysis
    Sarafidis, Pantelis
    Agarwal, Rajiv
    Pitt, Bertram
    Wanner, Christoph
    Filippatos, Gerasimos
    Boletis, John R.
    Tuttle, Katherine M.
    Ruilope, Luis
    Rossing, Peter
    Toto, Robert D.
    Anker, Stefan
    Liu, Zhi-Hong
    Joseph, Amer
    Ahlers, Christiane
    Brinker, Meike
    Lawatscheck, Robert
    Bakris, George
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 602 - 612
  • [44] SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE PHASE III TRIAL (GRID) OF REGORAFENIB IN PRETREATED METASTATIC GIST
    Kang, Y. -K.
    Xu, J.
    Komatsu, Y.
    Im, S. -A.
    Li, J.
    Nishida, T.
    Quek, R.
    Kappeler, C.
    Kuss, I.
    Demetri, G. D.
    Takimoto, R.
    ANNALS OF ONCOLOGY, 2013, 24
  • [45] Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer A Secondary Analysis of the SWOG 1216 Phase 3 Trial
    Sayegh, Nicolas
    Swami, Umang
    Jo, Yeonjung
    Gebrael, Georges
    Haaland, Benjamin
    Gupta, Shilpa
    Plets, Melissa
    Hussain, Maha H. A.
    Quinn, David I.
    Lara, Primo N., Jr.
    Thompson, Ian M., Jr.
    Agarwal, Neeraj
    JAMA NETWORK OPEN, 2023, 6 (08) : e2326546
  • [46] EFFICACY AND SAFETY OF ORAL SEMAGLUTIDE IN RUSSIAN PATIENTS WITH TYPE 2 DIABETES: SUBGROUP ANALYSIS OF PIONEER 1, 2, 3 TRIALS
    Shamkhalova, Minara Sh
    Shestakova, Marina, V
    DIABETES MELLITUS, 2022, 25 (03): : 204 - 214
  • [47] Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2
    Ostor, Andrew J. K.
    Soliman, Ahmed M.
    Papp, Kim A.
    Padilla, Byron
    Wang, Zailong
    Eldred, Ann
    de Vlam, Kurt
    Kivitz, Alan
    RMD OPEN, 2022, 8 (02):
  • [48] OUTCOME OF PATIENTS WITH DIABETES AND UNSTABLE ANGINA - A SUBGROUP ANALYSIS IN THE SPANISH MULTICENTER TRIAL OF TRIFUSAL IN UNSTABLE ANGINA
    GARCIARUBIRA, JC
    CRUZ, JM
    LOPEZ, V
    PLAZA, L
    NAVAS, JC
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1994, 46 (02) : 175 - 178
  • [49] CHRONIC ADMINISTRATION OF RIFAXIMIN FOR THE MAINTENANCE OF REMISSION OF HEPATIC ENCEPHALOPATHY: A SUBGROUP ANALYSIS OF A PHASE 3 TRIAL
    Sanyal, A.
    Bass, N.
    Teperman, L.
    Sigal, S.
    Hillebrand, D.
    Merchant, K.
    Huang, S.
    Shaw, A.
    Bortey, E.
    Forbes, W.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S90 - S90
  • [50] Subgroup analysis according to differentiated thyroid cancer histology in phase 3 (SELECT) trial of lenvatinib
    Elisei, R.
    Schlumberger, M.
    Tahara, M.
    Robinson, B.
    Brose, M.
    Dutcus, C.
    Zhu, J.
    Newbold, K.
    Kiyota, N.
    Kim, S. -B.
    Sherman, S.
    Wirth, L.
    Oncology Research and Treatment, 2015, 38 : 25 - 26
12345